Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin-induced phototoxicity in patients with cystic fibrosis
2005-003837-42Phase 4Terminated
- Sponsor
- Belfast City Hospital
- Start
- Aug 2005
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofloxacin in bacterial disease (2 arms), sponsored by Belfast City Hospital. Primary endpoints: Minimal erythema-inducing light dose before and after ciprofloxacin and Phototoxic index. Started Aug 2005; status: terminated.
02
Drugs
ciprofloxacin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2005-003837-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003837-42.